Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Human Genome Sciences has signed an exclusive agreement with Hospira, a specialty pharmaceutical and medication delivery company, for manufacturing process development and commercial supply of select Hospira biopharmaceutical products.
Subscribe to our email newsletter
In addition to the agreement with Hospira, Human Genome Sciences (HGS) has entered into a marketing services agreement with Eden Biodesign in mid-August 2008, under which Eden Biodesign will assist HGS in identifying other large- scale manufacturing and late-stage process development clients.
Curran Simpson, senior vice president of operations at HGS, said: “The priority focus of HGS continues to be the commercialization of our lead products. Agreements such as this one will produce near-term revenue from available manufacturing capacity. We see potential for $30-60 million in revenue from manufacturing alliances, including this alliance with Hospira, over the next three to four years.”